Interest Income (Expense), Operating

Name: Rigel Pharmaceuticals Interest Income (Expense), Operating by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Rigel Pharmaceuticals·Business Segments·1 segment·Rolls up to Net Interest Income

Breakdown

Segment	Q1 '26
Business Segments	-$228K
Total	—

Segments

Business SegmentsView metric